The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Use of PROMIS to capture patient reported outcomes over time for patients on I-SPY2.
 
Saya Jacob
No Relationships to Disclose
 
Hongmei Yu
No Relationships to Disclose
 
Denise M. Wolf
No Relationships to Disclose
 
Aheli Chattopadhyay
No Relationships to Disclose
 
Susie Brain
No Relationships to Disclose
 
Carol Simmons
No Relationships to Disclose
 
Kathryn Jean Ruddy
Research Funding - Medtronic (I)
Patents, Royalties, Other Intellectual Property - Spouse and Mayo Clinic have filed patents related to the application of artificial intelligence to the electrocardiogram for diagnosis and risk stratification. (I)
 
Irene Kang
Honoraria - Bristol Myer Squibb; Gilead Sciences; Puma Biotechnology
Consulting or Advisory Role - Caris Life Sciences
Speakers' Bureau - Puma Biotechnology
 
Anne Hudson Blaes
Research Funding - Dompé Farmaceutici
 
Amrita B Somani
Travel, Accommodations, Expenses - Leidos Health
 
Dawn L. Hershman
Consulting or Advisory Role - AIM Specialty Health
 
Laura Esserman
Consulting or Advisory Role - Blue Cross Blue Shield Association
Research Funding - Merck
Travel, Accommodations, Expenses - Blue Cross Blue Shield Association
(OPTIONAL) Uncompensated Relationships - Quantum Leap Healthcare Collaborative
 
Michelle E. Melisko
Stock and Other Ownership Interests - Merrimack (I)
Speakers' Bureau - AstraZeneca (I); Genentech (I); Gilead Sciences (I)
Research Funding - DAEHWA Pharmaceutical (Inst); Novartis (Inst); OBI Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Multiple patents related to immunoliposomal drugs being studied and potentially brought to market by Merrimack (I)
Expert Testimony - GlaxoSmithKline